Virtu Financial LLC Abbott Laboratories Transaction History

Virtu Financial LLC

$1.82 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$100.73 - $112.44 $1.91 Million - $2.13 Million	-18,921 Reduced 49.39%	19,390 $2.02 Million
Q1 2024 May 20, 2024	BUY	$109.52 - $120.96 $4.2 Million - $4.63 Million	38,311 New	38,311 $4.35 Million
Q1 2023 May 01, 2023	BUY	$96.86 - $114.01 $2.11 Million - $2.49 Million	21,814 Added 298.33%	29,126 $2.95 Million
Q4 2022 Feb 15, 2023	SELL	$95.06 - $111.52 $65,971 - $77,394	-694 Reduced 8.67%	7,312 $803,000
Q3 2022 Nov 07, 2022	SELL	$96.76 - $112.03 $1.31 Million - $1.52 Million	-13,584 Reduced 62.92%	8,006 $775,000
Q2 2022 Aug 09, 2022	BUY	$102.07 - $123.37 $126,668 - $153,102	1,241 Added 6.1%	21,590 $2.35 Million
Q1 2022 May 17, 2022	BUY	$114.02 - $139.04 $2.05 Million - $2.5 Million	17,950 Added 748.23%	20,349 $2.41 Million
Q4 2021 Feb 17, 2022	SELL	$115.53 - $141.46 $1.66 Million - $2.04 Million	-14,404 Reduced 85.72%	2,399 $338,000
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $1.96 Million - $2.17 Million	16,803 New	16,803 $1.99 Million
Q2 2021 Sep 17, 2021	SELL	$105.79 - $124.53 $779,989 - $918,159	-7,373 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$108.84 - $128.23 $802,477 - $945,439	7,373 New	7,373 $884,000
Q3 2020 Dec 11, 2020	SELL	$91.64 - $111.29 $203,440 - $247,063	-2,220 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$76.57 - $98.0 $356,356 - $456,092	-4,654 Reduced 67.7%	2,220 $203,000
Q4 2019 Feb 04, 2020	BUY	$78.51 - $87.4 $277,532 - $308,959	3,535 Added 105.87%	6,874 $597,000
Q3 2019 Nov 20, 2019	SELL	$81.84 - $88.74 $656,766 - $712,138	-8,025 Reduced 70.62%	3,339 $279,000
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $597,105 - $696,405	8,193 Added 258.37%	11,364 $956,000
Q1 2019 Apr 12, 2019	BUY	$66.22 - $80.06 $209,983 - $253,870	3,171 New	3,171 $253,000
Q4 2018 Jan 16, 2019	SELL	$65.56 - $74.27 $732,305 - $829,595	-11,170 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $679,247 - $819,431	11,170 New	11,170 $819,000
Q2 2018 Jul 30, 2018	SELL	$57.57 - $63.54 $1.83 Million - $2.02 Million	-31,817 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$57.57 - $63.54 $1.83 Million - $2.02 Million	31,817 New	31,817 $1.94 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $1.27 Million - $1.43 Million	-22,543 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$53.68 - $57.47 $311,451 - $333,440	-5,802 Reduced 20.47%	22,543 $1.29 Million
Q3 2017 Nov 15, 2017	BUY	$48.06 - $53.64 $1.36 Million - $1.52 Million	28,345	28,345 $2,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$20 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.6 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.13 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.82 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.34 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Account